Form 4: Amkor Director Sells 20,000 Shares Under 10b5-1 Plan

Amkor Technology Director Gil C. Tily sold 20,000 shares of common stock for a weighted average price of $46.44, executed under a Rule 10b5-1 plan.

Summary

• Gil C. Tily, a Director of Amkor Technology, Inc. (AMKR), disposed of 20,000 shares of common stock.
• The transaction occurred on December 12, 2025.
• The shares were sold at a weighted average price of $46.44 per share.
• The sale price ranged from $45.91 to $46.83 per share.
• Following this transaction, Gil C. Tily beneficially owns 123,806 shares of Amkor Technology common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: A director's sale of shares, especially under a Rule 10b5-1 plan, is a routine event and does not inherently indicate a positive or negative outlook on the company's future performance. The pre-planned nature reduces the impact of the sale.

Positives

• The sale was executed under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on new, non-public information, which mitigates potential negative interpretations of insider selling.

Negatives

• A director's sale of shares, even under a pre-arranged plan, reduces their direct ownership stake in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders might observe insider selling, which could be interpreted in various ways, though the disclosure of a 10b5-1 plan generally mitigates negative interpretations as it suggests the sale was not based on new, non-public information.

Key Dates

Recommendation

The sale of shares by a director, particularly when executed under a pre-arranged Rule 10b5-1 plan, is generally considered a routine personal financial management event rather than an indicator of the company's future prospects. This transaction alone does not provide sufficient new information to alter an existing investment thesis for Amkor Technology, Inc.

Keywords

Amkor Technology, AMKR, Insider Sale, Director Transaction, Form 4, Equity Sale, Stock Sale, 10b5-1 Plan